[1]张海珍.麦角新碱联合缩宫素预防瘢痕子宫剖宫产产后出血的疗效[J].医学信息,2024,37(15):127-129,133.[doi:10.3969/j.issn.1006-1959.2024.15.029]
　ZHANG Hai-zhen.Efficacy of Ergometrine Combined with Oxytocin in Preventing Postpartum Hemorrhage of Cesarean Section of Scarred Uterus[J].Journal of Medical Information,2024,37(15):127-129,133.[doi:10.3969/j.issn.1006-1959.2024.15.029]
点击复制

麦角新碱联合缩宫素预防瘢痕子宫剖宫产产后出血的疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年15期
页码:
127-129,133
栏目:
论著
出版日期:
2024-08-01

文章信息/Info

Title:
Efficacy of Ergometrine Combined with Oxytocin in Preventing Postpartum Hemorrhage of Cesarean Section of Scarred Uterus
文章编号:
1006-1959（2024）15-0127-04
作者:
张海珍
（遂川县妇幼保健院临床妇产科，江西 遂川 343900）
Author(s):
ZHANG Hai-zhen
(Department of Clinical Obstetrics and Gynecology,Suichuan County Maternal and Child Health Hospital,Suichuan 343900,Jiangxi,China)
关键词:
产后出血; 瘢痕子宫; 剖宫产; 麦角新碱; 缩宫素
Keywords:
Postpartum hemorrhage; Scarred uterus; Caesarean section; Ergometrine; Oxytocin
分类号:
R719.8
DOI:
10.3969/j.issn.1006-1959.2024.15.029
文献标志码:
A
摘要:
目的 探究麦角新碱联合缩宫素预防瘢痕子宫（SU）剖宫产产后出血的临床作用。方法 选取2021年1月-2023年5月遂川县妇幼保健院拟行剖宫产分娩的60例SU产妇，经随机数字表法分为对照组（30例）与观察组（30例），对照组给予缩宫素处理，观察组则采用麦角新碱联合缩宫素处理，比较两组PPH预防效果、出血量（术后12、24 h）、输血率、血红蛋白（Hb）、产后恢复情况（术后住院时间、子宫底下降速度）、不良反应发生率。结果 观察组产后出血预防有效率高于对照组（P＜0.05）；观察组术后12、24 h出血量均少于对照组，且输血率小于对照组（P＜0.05）；两组术后24 h的Hb水平均低于术前（P＜0.05），但组间比较，差异无统计学意义（P＞0.05），而观察组Hb下降值小于对照组（P＜0.05）；两组不良反应发生率比较，差异无统计学意义（P＞0.05）；观察组术后住院时间短于对照组，且子宫底下降速度大于对照组（P＜0.05）。结论 麦角新碱联合缩宫素对SU剖宫产产后出血具有良好预防作用，可降低产妇产后出血量，减少其血红蛋白流失，加速产后恢复，且具有较高用药安全性。
Abstract:
Objective To explore the clinical effect of ergometrine combined with oxytocin in preventing postpartum hemorrhage of scarred uterus (SU) after cesarean section.Methods From January 2021 to May 2023, 60 SU parturients undergoing cesarean section in Suichuan County Maternal and Child Health Hospital were selected and divided into control group (30 parturients) and observation group (30 parturients) by random number table method. The control group was treated with oxytocin, while the observation group was treated with ergometrine combined with oxytocin. The preventive effect of PPH, postpartum hemorrhage (12 h and 24 h after operation), blood transfusion rate, hemoglobin (Hb), postpartum recovery (postoperative hospitalization time, uterine fundus decline rate) and incidence of adverse reactions were compared between the two groups.Results The effective rate of postpartum hemorrhage prevention in the observation group was higher than that in the control group (P<0.05). The amount of bleeding at 12 and 24 h after operation in the observation group was less than that in the control group, and the blood transfusion rate was less than that in the control group (P<0.05). The Hb level of the two groups at 24 h after operation was lower than that before operation(P<0.05), but there was no significant difference between the two groups (P>0.05), while the decrease of Hb in the observation group was less than that in the control group(P<0.05). The postoperative hospitalization time of the observation group was shorter than that of the control group, and the decline rate of the uterine fundus was greater than that of the control group (P<0.05).Conclusion Ergometrine combined with oxytocin has a good preventive effect on postpartum hemorrhage of SU cesarean section, which can reduce the amount of postpartum hemorrhage, reduce the loss of hemoglobin, accelerate postpartum recovery, and has high drug safety.

参考文献/References:

[1]左志洪,陈岩飞,赵影.麦角新碱联合缩宫素治疗宫缩乏力性产后出血的效果及对应激相关指标的影响[J].河北医药,2023,45(6):879-882.[2]陈岩飞,赵影,左志洪.麦角新碱联合缩宫素治疗高龄剖宫产产妇产后出血的效果及对应激指标的影响[J].临床误诊误治,2022,35(11):36-40.[3]Hochler H,Wainstock T,Lipschuetz M,et al.Induction of labor in women with a scarred uterus: Does grandmultiparity affect the risk of uterine rupture?[J].American Journal of Obstetrics & Gynecology MFM,2019,2(1):100081.[4]符秋语,符浮,杨帅.剖宫产产后出血应用卡贝缩宫素联合麦角新碱的效果及危险因素分析[J].中国药业,2022,31(17):101-104.[5]刘伟娟,张艳利.缩宫素+马来酸麦角新碱治疗产后出血的有效性及对恢复效果的影响[J].贵州医药,2022,46(5):756-758.[6]仇茜,姚荣华,黄俊杰,等.麦角新碱与卡前列素氨丁三醇联合预防瘢痕子宫再次剖宫产患者产后出血的效果及对GSH-px SOD MDA产后泌乳情况的影响[J].河北医学,2021,27(11):1901-1907.[7]李晓芬.马来酸麦角新碱和卡贝缩宫素预防高危孕产妇剖宫产术后产后出血的效果[J].中国妇幼保健,2021,36(12):2708-2711.[8]李丙森,刘虎,孙夷平.缩宫素联合不同前列素类药物对瘢痕子宫剖宫产产后出血的预防效果比较[J].安徽医学,2021,42(6):651-653.[9]乔宠,刘彩霞,赵扬玉.高龄妇女瘢痕子宫再妊娠管理专家共识(2021年版)[J].中国实用妇科与产科杂志,2021,37(5):558-563.[10]袁梅,余婧.麦角新碱联合卡贝缩宫素预防剖宫产产后出血效果及对炎症因子水平的影响研究[J].贵州医药,2021,45(3):412-413.[11]郑娟,刘艳萍.卡贝缩宫素、麦角新碱联合子宫压缩缝合预防瘢痕子宫剖宫产产后出血效果[J].中国计划生育学杂志,2020,28(6):922-924,930.[12]Palacios-Jaraquemada JM,Basanta NA,Nieto-Calvache ?魣J.Advanced repair of recurrent and low-large hysterotomy defects using a myometrial glide flap[J].J Matern Fetal Neonatal Med,2024,37(1):2365344.[13]韩秀慧,李增彦.马来酸麦角新碱联合卡前列素氨丁三醇治疗二次剖宫产产后出血患者的临床研究[J].中国临床药理学杂志,2020,36(6):606-609.[14]贾源君,焦娜.马来酸麦角新碱联合卡贝缩宫素预防瘢痕子宫妊娠产后出血效果[J].中国计划生育学杂志,2020,28(3):345-348.[15]刘叶廷,吴彦英,李凤娇,等.氨甲环酸联合缩宫素与麦角新碱预防二次剖宫产产后出血的临床研究[J].河北医药,2022,44(21):3305-3307.[16]吴亚萍,瞿福娟,郭楚.卡孕栓联合缩宫素对瘢痕子宫剖宫产产后出血的预防效果[J].海南医学,2019,30(19):2518-2520.[17]赵洁,禹宏,徐毛毛,等.麦角新碱联合卡贝缩宫素预防剖宫产产后出血效果分析[J].中南医学科学杂志,2019,47(4):421-424.[18]秦红,徐红兵,杨晓畅.预防性使用马来酸麦角新碱与缩宫素在第三产程应用的观察研究[J].重庆医学,2019,48(15):2684-2685,2700.[19]韩慧慧,冯翀,黑江荣.卡前列素氨丁三醇联合缩宫素对剖宫产产后出血的疗效及对氧化应激凝血功能的影响[J].河北医学,2018,24(11):1833-1837.[20]汪俊丽,胡南英,魏岩.缩宫素联合麦角新碱与单纯应用缩宫素预防选择性剖宫产产后出血的疗效与安全性研究[J].中国药理学通报,2018,34(9):1331-1332.[21]卫蔷,张力,吴琳,等.麦角新碱联合卡贝缩宫素与单用缩宫素预防剖宫产产后出血研究[J].中国实用妇科与产科杂志,2018,34(6):640-644.[22]Gil-Rojas Y,Lasalvia P,Hernández F,et al.Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia[J].Rev Bras Ginecol Obstet,2018,40(5):242-250.[23]陈怡.卡前列素氨丁三醇、麦角新碱、缩宫素三联疗法预防产后出血的临床疗效观察[J].中国妇幼保健,2018,33(6):1266-1268.[24]金萍,石少权.麦角新碱联合缩宫素治疗临产后剖宫产产后出血的临床观察[J].药物评价研究,2018,41(2):302-304.

相似文献/References:

[1]崔玉萍.子宫压迫缝合术在产后出血治疗中的应用效果观察[J].医学信息,2018,31(01):98.[doi:10.3969/j.issn.1006-1959.2018.01.035]
　CUI Yu-ping.Observation of the Effect of Uterine Compression Suture in the Treatment of Postpartum Hemorrhage[J].Journal of Medical Information,2018,31(15):98.[doi:10.3969/j.issn.1006-1959.2018.01.035]
[2]游琪华.循证护理与单纯全程陪产护理模式在产科分娩中的应用与对比研究[J].医学信息,2018,31(01):179.[doi:10.3969/j.issn.1006-1959.2018.01.072]
　YOU Qi-hua.The Application and Comparative Study of Evidence-based Nursing and Pure Whole Course Paternity Nursing Mode in Obstetric Delivery[J].Journal of Medical Information,2018,31(15):179.[doi:10.3969/j.issn.1006-1959.2018.01.072]
[3]刘 礼.影响剖宫产术后瘢痕子宫足月分娩结局的相关因素分析[J].医学信息,2018,31(02):109.[doi:10.3969/j.issn.1006-1959.2018.02.039]
　LIU Li.Analysis of Related Factors Influencing the Outcome of Full Term Delivery of Scar Uterus after Cesarean Section[J].Journal of Medical Information,2018,31(15):109.[doi:10.3969/j.issn.1006-1959.2018.02.039]
[4]薛志雯.瘢痕子宫再次妊娠选择不同分娩方式的效果分析[J].医学信息,2018,31(04):186.[doi:10.3969/j.issn.1006-1959.2018.04.071]
　XUE Zhi-wen.Analysis of Different Delivery Modes in the Second Pregnancy of Scar Uterus[J].Journal of Medical Information,2018,31(15):186.[doi:10.3969/j.issn.1006-1959.2018.04.071]
[5]张朝霞.瘢痕子宫再次妊娠阴道分娩的可行性及安全性评价[J].医学信息,2018,31(06):104.[doi:10.3969/j.issn.1006-1959.2018.06.033]
　ZHANG Zhao-xia.Feasibility and Safety Evaluation of Vaginal Delivery after Re-pregnancy in Scared Uterus[J].Journal of Medical Information,2018,31(15):104.[doi:10.3969/j.issn.1006-1959.2018.06.033]
[6]岳凤洁.二次剖宫产术后并发症发生情况的临床分析[J].医学信息,2018,31(08):114.[doi:10.3969/j.issn.1006-1959.2018.08.038]
　YUE Feng-jie.Clinical Analysis of Complications after Secondary Cesarean Section[J].Journal of Medical Information,2018,31(15):114.[doi:10.3969/j.issn.1006-1959.2018.08.038]
[7]宋晓娟.COOK水囊在瘢痕子宫足月妊娠经阴道分娩中的应用[J].医学信息,2018,31(21):112.[doi:10.3969/j.issn.1006-1959.2018.21.031]
　SONG Xiao-juan.Application of COOK Water Sac in Vaginal Delivery of Full-term Pregnancy of ScarredUterus[J].Journal of Medical Information,2018,31(15):112.[doi:10.3969/j.issn.1006-1959.2018.21.031]
[8]蒋红梅.子宫B-Lynch缝合技术在预防剖宫产产后出血中的应用价值[J].医学信息,2019,32(06):130.[doi:10.3969/j.issn.1006-1959.2019.06.042]
　JIANG Hong-mei.The Application Value of Uterine B-Lynch Suture Technique in Preventing Postpartum Hemorrhage of Cesarean Section[J].Journal of Medical Information,2019,32(15):130.[doi:10.3969/j.issn.1006-1959.2019.06.042]
[9]原心玥,胡玉红,冯晓娜.葆宫止血颗粒联合卡前列素氨丁三醇注射液对剖宫产产后出血的防治研究[J].医学信息,2019,32(06):154.[doi:10.3969/j.issn.1006-1959.2019.06.049]
　YUAN Xin-yue,HU Yu-hong,FENG Xiao-na.Prevention and Treatment of Postpartum Hemorrhage after Cesarean Section with BaogongZhixueGranulesCombined with Carboprost Tromethamine Injection[J].Journal of Medical Information,2019,32(15):154.[doi:10.3969/j.issn.1006-1959.2019.06.049]
[10]黄伟彪,张 金,杨佰郁,等.产后出血栓塞治疗的新进展[J].医学信息,2019,32(18):21.[doi:10.3969/j.issn.1006-1959.2019.18.008]
　HUANG Wei-biao,ZHANG Jin,YANGBai-yu,et al.New Progress in Postpartum Thromboembolism[J].Journal of Medical Information,2019,32(15):21.[doi:10.3969/j.issn.1006-1959.2019.18.008]
[11]王金英.卡前列甲酯栓联合麦角新碱预防瘢痕子宫剖宫产产后出血的临床效果及安全性[J].医学信息,2023,36(23):107.[doi:10.3969/j.issn.1006-1959.2023.23.027]
　WANG Jin-ying.Clinical Effect and Safety of Methyl Carprost Suppositories Combined with Ergonovine in Preventing Postpartum Hemorrhage of Cesarean Section of Scar Uterus[J].Journal of Medical Information,2023,36(15):107.[doi:10.3969/j.issn.1006-1959.2023.23.027]

更新日期/Last Update: 1900-01-01